A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF
Clinical trial NCT03864328 · TERMINATED
Trial details
- NCT number
- NCT03864328
- Sponsor
- Respivant Sciences GmbH
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-29
- Primary completion
- 2020-05-29
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.